Coris > Products > Influ A+B K-SeT > Science
Peretz A, Zadok BS, Azrad M
Diagn Microbiol Infect Dis. 2020 Sep;98(1):115097
Abstract
To evaluate the performance of Influ A + B K-SeT®, a rapid influenza antigen detection kit, in order to determine whether its implementation as a point-of-care test in the emergency room (ER) is justified. Nasopharyngeal swabs (n = 170) were collected in triplicates from patients with suspected influenza infection. One sample was tested by the Influ A + B K-SeT® kit and the other two samples were analyzed with Simplexa™ Flu A/B & RSV Direct Kit and Xpert® Flu, two RT-PCR-based assays routinely used in the ER. The sensitivity and specificity of the Influ A + B K-SeT® kit were 91.2%-94.5% and 98.2%, respectively, compared to the Xpert® Flu assay and the Simplexa™ Flu A/B & RSV Direct Kit, respectively. Considering the satisfactory diagnostic performance of the Influ A + B K-SeT® test, its implementation as a point-of-care is expected to aid in decision-making, minimize time-to-result and reduce healthcare costs.
https://pubmed.ncbi.nlm.nih.gov/32599417/
Vandamme S, Van Cleempoel S, Michiels M, Goossens H, Jansens H, Matheeussen V.
https://www.ncbi.nlm.nih.gov/pubmed/30827806
Evaluation of the Coris Influ A+B K-SeT (type Influenza A)